XBiotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 47.91% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.86%	Thomas Gut	3,914,111	$17.0m	0%	no data
12.56%	John Simard	3,823,166	$16.6m	0%	no data
8.66%	W. McKenzie	2,637,011	$11.5m	0%	no data
3.66%	Blackstone Inc.	1,114,256	$4.8m	0%	0.02%
2.81%	The Vanguard Group, Inc.	854,117	$3.7m	-0.02%	no data
0.85%	BlackRock, Inc.	258,934	$1.1m	1.57%	no data
0.85%	MultiConcept Fund Management S.A.	258,708	$1.1m	16.99%	0.03%
0.66%	Jan-Paul Waldin	200,243	$871.1k	0%	no data
0.51%	Renaissance Technologies LLC	155,468	$676.3k	97.63%	no data
0.5%	Geode Capital Management, LLC	151,741	$660.1k	0.23%	no data
0.45%	Millennium Management LLC	137,987	$600.2k	-51.53%	no data
0.45%	Oasis Management Company Ltd.	137,174	$596.7k	0%	0.03%
0.44%	Bridgeway Capital Management, LLC	133,000	$578.6k	336.07%	0.01%
0.33%	Morgan Stanley, Investment Banking and Brokerage Investments	100,131	$435.6k	-36%	no data
0.29%	Queena Han	87,692	$381.5k	0%	no data
0.28%	Dimensional Fund Advisors LP	86,273	$375.3k	-48.37%	no data
0.25%	Two Sigma Investments, LP	77,097	$335.4k	22.28%	no data
0.23%	Two Sigma Advisers, LP	69,300	$301.5k	117.92%	no data
0.22%	Connor, Clark & Lunn Investment Management Ltd.	67,975	$295.7k	38.41%	no data
0.22%	Mckenzie Charitable Foundation, Endowment Arm	66,748	$290.4k	0%	no data
0.19%	State Street Global Advisors, Inc.	57,295	$249.2k	-0.73%	no data
0.18%	BNY Mellon Asset Management	55,693	$242.3k	0%	no data
0.16%	D. E. Shaw & Co., L.P.	48,149	$209.4k	36.28%	no data
0.15%	Acadian Asset Management LLC	45,450	$197.7k	-8.18%	no data
0.15%	Northern Trust Global Investments	44,828	$195.0k	1.71%	no data